KIT and mastocytosis: Altogether, these observations support the need for implementation of extended genetic analyses beyond the study of the D816V KIT mutation in the diagnostic work-up of mastocytosis which could help to select for those patients with AdvSM who will require more aggressive therapies, and to identify a subgroup of patients with ISM at risk of progression for whom a closer follow-up should be recommended.